key: cord-0975341-0085z4vx
authors: Khan, Amjad; Bibi, Salma; Kanwal, Hafsa; Umm‐e‐Kalsoom,; Hussain, Hidayat
title: Omicron: A new face of COVID‐19 pandemic
date: 2022-02-18
journal: Health Sci Rep
DOI: 10.1002/hsr2.526
sha: 9d721c9fb531fcaa948bd87da9778043a863e839
doc_id: 975341
cord_uid: 0085z4vx

nan

detection of previous strains, continues to detect the Omicron variant. 1 Corticosteroids and IL-6 receptor blockers have shown efficacy to manage severe infections with Omicron as for its antecedents. 2 Food and Drug Administration has recently approved Paxlovid and monoclonal antibodies (Softrovimab) that have shown promising results to fight against Coronavirus; Molnupiravir is also under consideration. 8 A new Coronavirus antibody, Xevudy (Sotrovimab), has been approved by the Medicines and Healthcare Products Regulatory Agency and is claimed to have effectiveness against Omicron. 9 The detection of Omicron has triggered the global alarm, WHO reports that the spread of omicron is so fast that has not been observed for any previous Coronavirus strains. 1 So far, Omicron has been detected in more than 108 countries across all continents. 6

Emergence of Omicron is a stark reminder of ongoing threat by con- 

Runny nose, fatigue (mild-severe), headache, sore throat, and sneezing. Omicron is more likely to infect upper respiratory tract than lungs, thus making it more infectious and less deadly than previous variants. 4,5

Populations having no immunization status are at higher risk of infections from Omicron with more severe attack. 2 According to UK Health Security Agency (UKSHA), third COVID-19 vaccine dose (booster) can provide higher protection against Omicron and reduces the risk of hospitalization up to 88% in infected patients. 6

Reinfection rate

In comparison to other VOCs, Omicron poses a higher risk of reinfection. 1 A person who was previously infected with COVID-19, has 5 1/2 % more risk of reinfection with Omicron than reinfection with Delta variant. 7

Highly mutated SARS-CoV-2 omicron variant sparks significant concern among global experts-what is known so far

An imported case of BA. 2 lineage of omicron variant COVID-19

Covid-19: Runny nose, headache, and fatigue are commonest symptoms of omicron, early data show. 2021. 6

?cx= 014389848304649563256%3Aureyfztd74a&cof=FORID%3A10& ie=UTF-8&q=omicron. Accessed